Arcus Biosciences

Exciting young company founded on a vision of creating new cancer therapeutics through the utilization of emerging insights in immunology.

Launch date

2015

Employees

501-1000 people

Market cap

Net debt

-

Enterprise valuation

$680m (Public information from May 2024)

Hayward California (HQ)

https://www.arcusbio.com/

https://twitter.com/arcusbio https://www.facebook.com/pages/Arcus-Biosciences/949081105141002 https://www.linkedin.com/company/arcus-biosciences

View job openings

Authorizing premium user...